Author: Arnold Kendrick - Page 3

Digital eye strain affects millions daily. Learn simple, science-backed ways to prevent Computer Vision Syndrome-like the 20-20-20 rule, proper screen setup, and blinking habits-without expensive gear.

Retinal vein occlusion can cause sudden vision loss. Learn the key risk factors like high blood pressure and diabetes, and how anti-VEGF injections help restore vision. Understand treatment options, costs, and what to expect.

Therapeutic drug monitoring helps protect patients on generic HIV drugs by measuring blood levels to prevent toxicity and treatment failure-especially for protease inhibitors and NNRTIs. Not for all drugs, but critical in high-risk cases.

Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.

Learn how to safely talk to your doctor about stopping or tapering a medication. Understand withdrawal risks, tapering timelines, and what to ask to protect your health.

Long-term studies show generics are generally as safe as brand-name drugs, but key differences emerge for high-risk medications and certain manufacturers. Learn when switching could affect your health and what to ask your pharmacist.

FDA drug labels are full of complex data, but patients need clear answers. Learn how benefit-risk statements work, where they fall short, and what you can do to understand your medication's real trade-offs.

Learn how to talk to your doctor about medication side effects without quitting your treatment. Discover proven strategies to track symptoms, communicate effectively, and stay on your medication for better long-term health.

Fish oil and aspirin together don’t significantly increase bleeding risk at standard doses. Big studies show no added danger - but high doses need caution. Here’s what you really need to know.

Biosimilars aren't exact copies of biologics - tiny manufacturing differences can trigger immune responses. Learn why some patients develop antibodies, how administration and genetics affect risk, and what real-world data really shows.